Home / Mumbai / Mumbai News / Article / Maharashtra FDA orders stop on sale of Coldrif syrup linked to 14 deaths

Maharashtra FDA orders stop on sale of Coldrif syrup linked to 14 deaths

The FDA has instructed all licence holders, retailers, hospitals, and the public to immediately stop the sale, distribution, or use of this batch and to report its possession to local Drug Control Authorities without delay

Listen to this article :
An official looks at bottles of the ‘Coldrif’ cough syrup after a raid by the Drug and Pharmaceuticals Department officials at Kataria Pharmaceuticals. Pic/PTI

An official looks at bottles of the ‘Coldrif’ cough syrup after a raid by the Drug and Pharmaceuticals Department officials at Kataria Pharmaceuticals. Pic/PTI

The Food and Drugs Administration (FDA) in Maharashtra on Sunday issued an urgent alert following reports of child deaths in Madhya Pradesh and Rajasthan allegedly linked to a contaminated batch of Coldrif Syrup.

According to an official notification, the syrup, manufactured by Sresan Pharma in Tamil Nadu, is suspected to have been adulterated with Diethylene Glycol (DEG),  a toxic chemical reportedly known to cause serious harm or even death if consumed.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement